The Impact of Clinical Pharmacist in the Identification and Management of Treatment Related Problems in the Surgery Ward

University of Jordan

Status: Completed

Conditions: Surgical Patients

Treatments: Other: clinical pharmacist intervention

Study type: Interventional

Funder types: Other

Identifiers

NCT04941820

80/2019/1943

Details and patient eligibility

About

Patients in the surgery ward are at risk of morbidity and mortality from various types of treatment-related problems (TRPs). The primary aim of this study is to assess the impact of the clinical pharmacist in the identification and management of TRPs in the surgery ward.

Full description

Patients were randomly assigned to intervention (n=50) and usual care (n=50) arms. The clinical pharmacist assessed the types, frequencies, and clinical significance of TRPs for all recruited patients at baseline. Patients and treating surgeons in the intervention arm received recommendations concerning the identified TRPs, while the usual care arm did not. The number of TRPs was reevaluated at follow-up.

Enrollment: 100 patients

Sex: All

Ages: 18+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Admission for elective, urgent, or emergency surgery
• age 18 years or older
• Expected length of stay of 3 days or more in the general surgical ward or the SICU

Exclusion criteria

• Pregnancy, breastfeeding, drug or alcohol abuse, active malignancy, or admission for plastic surgery

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

100 participants in 2 patient groups

Clinical pharmacist intervention + usual care arm

Experimental group

Description:

Patients in the clinical pharmacist intervention + usual care arm received the clinical pharmacist intervention as well as usual care provided by the surgical team

Treatment:

Other: clinical pharmacist intervention

Usual care arm (Control arm)

No Intervention group

Description:

Patients in the control arm received usual care by the surgical team without a coordinated contribution from the clinical pharmacist